secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0000950170-22-023229
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q3 revenue $27.8M (+5.5% YoY); raises 2022 guidance to $111-113M
-------------------------------------------------------------------------------

- Revenue $27.8M, +5.5% YoY and +10.8% QoQ; gross margin 15.6% vs 11.2% YoY.
- Net loss ($40.8M) / ($0.85) per share; non-GAAP EPS ($0.70).
- Raises FY2022 revenue guidance to $111M-$113M from $105M-$110M.
- Awarded 5-year VA contract for Tablo at 106 VA hospitals and home settings.
- Secured up to $300M in debt financing to strengthen balance sheet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017022023229/0000950170-22-023229-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017022023229/om-20221108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-023229

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer